Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Apr;16(3):549-550.
doi: 10.1007/s11739-020-02603-w. Epub 2021 Mar 13.

Adverse drug reactions in the era of COVID-19

Angela P Cornelius  1
Affiliations
Comment

Adverse drug reactions in the era of COVID-19

Angela P Cornelius. Intern Emerg Med. 2021 Apr.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Comment on

References

    1. Crescioli G, Brilli V, Lanzi C, Burgalassi A, Ieri A, Bonaiuti R, Romano E, Innocenti R, Mannaioni G, Vannacci A, Lombardi N. Adverse drug reactions in SARS-CoV-2 hospitalised patients: a case-series with a focus on drug-drug interactions. Intern Emerg Med. 2020 doi: 10.1007/s11739-020-02586-8. - DOI - PMC - PubMed
    1. Sanders JM, Monogue ML, Jodlowski TZ, Cutrell JB. Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review. JAMA. 2020;323(18):1824–1836. doi: 10.1001/jama.2020.6019. - DOI - PubMed
    1. Choi Y, Lim HS, Chung D, Choi JG, Yoon D (2018) Risk evaluation of azithromycin-induced QT prolongation in real-world practice. BioMed Res Int 2018:1574806, 8 pp. 10.1155/2018/1574806 - PMC - PubMed
    1. Chu CM, Cheng VC, Hung IF, Wong MM, Chan KH, Chan KS, Kao RY, Poon LL, Wong CL, Guan Y, Peiris JS, Yuen KY, HKU/UCH SARS Study Group Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax. 2004;59(3):252–256. doi: 10.1136/thorax.2003.012658. - DOI - PMC - PubMed
    1. Khalili JS, Zhu H, Mak NSA, Yan Y, Zhu Y. Novel coronavirus treatment with ribavirin: groundwork for an evaluation concerning COVID-19. J Med Virol. 2020;92(7):740–746. doi: 10.1002/jmv.25798. - DOI - PMC - PubMed

Substances

LinkOut - more resources